MedTrace Logo

Central Sensitization Inventory and Symptoms of Pelvic Floor Dysfunctions

NCT07154576 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 359

Last updated 2026-04-16

No results posted yet for this study

Summary

The goal of this observational study is to assess the values of Central Sensitization Inventory in women in a gynecology outpatient clinic. The main question it aims to answer is:

Is there a relationship between outcomes of Central Sensitization Inventory and symptoms of pelvic floor dysfunctions reported by the patients?

Participants will complete questionnaires: Central Sensitization Inventory and questionnaires assessing pelvic floor dysfunctions and their impact on quality of life (PFDI-20, PFIQ-7, PISQ-12).

Conditions

  • Pelvic Floor Dysfunctions

Sponsors & Collaborators

  • Żelazna Medical Centre, LLC

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-28
Primary Completion
2026-05-30
Completion
2026-08-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07154576 on ClinicalTrials.gov